By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Investment bank Jefferies today restarted coverage of Complete Genomics with a 'Buy' rating and $20 price target.

Jefferies had recently served as joint book-runner for Complete Genomics' secondary offering, which raised net proceeds of $73.8 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.